These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31487678)

  • 1. Decreasing Use of Chemotherapy in Older Patients With Stage III Colon Cancer Irrespective of Comorbidities.
    Walter V; Boakye D; Weberpals J; Jansen L; Haefeli WE; Martens UM; Knebel P; Chang-Claude J; Hoffmeister M; Brenner H
    J Natl Compr Canc Netw; 2019 Sep; 17(9):1089-1099. PubMed ID: 31487678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of Variation in the Use of Adjuvant Chemotherapy for Stage III Colon Cancer in England.
    Boyle JM; Kuryba A; Cowling TE; Aggarwal A; Hill J; van der Meulen J; Walker K; Braun MS
    Clin Oncol (R Coll Radiol); 2020 May; 32(5):e135-e144. PubMed ID: 31926818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reasons for Underuse of Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.
    Ko JJ; Kennecke HF; Lim HJ; Renouf DJ; Gill S; Woods R; Speers C; Cheung WY
    Clin Colorectal Cancer; 2016 Jun; 15(2):179-85. PubMed ID: 26520019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why adjuvant chemotherapy for stage III colon cancer was not given: Reasons for non-recommendation by clinicians or patient refusal.
    Gilbar P; Lee A; Pokharel K
    J Oncol Pharm Pract; 2017 Mar; 23(2):128-134. PubMed ID: 26692241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern Netherlands.
    van Steenbergen LN; Rutten HJT; Creemers GJ; Pruijt JFM; Coebergh JWW; Lemmens VEPP
    Ann Oncol; 2010 Jun; 21(6):1273-1278. PubMed ID: 19880434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
    Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL
    J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.
    Brungs D; Aghmesheh M; de Souza P; Carolan M; Clingan P; Rose J; Ranson M
    Clin Colorectal Cancer; 2018 Sep; 17(3):e549-e555. PubMed ID: 29861156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer.
    van der Geest LG; Portielje JE; Wouters MW; Weijl NI; Tanis BC; Tollenaar RA; Struikmans H; Nortier JW;
    Colorectal Dis; 2013; 15(10):e582-91. PubMed ID: 23679338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of chemotherapy in older patients with stage II and III colon cancer: Variation by age and era of diagnosis.
    Green SL; Dawe DE; Nugent Z; Cheung WY; Czaykowski PM
    J Geriatr Oncol; 2019 Jan; 10(1):132-137. PubMed ID: 30104156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographic variation and sociodemographic disparity in the use of oxaliplatin-containing chemotherapy in patients with stage III colon cancer.
    Panchal JM; Lairson DR; Chan W; Du XL
    Clin Colorectal Cancer; 2013 Jun; 12(2):113-21. PubMed ID: 23137529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea.
    Kim JY; Kim YJ; Lee KW; Lee JS; Kim DW; Kang SB; Lee HS; Jang NY; Kim JS; Kim JH
    Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of adjuvant chemotherapy in older patients with Stage III colon cancer: an observational study.
    van den Broek CBM; Puylaert CCEM; Breugom AJ; Bastiaannet E; de Craen AJM; van de Velde CJH; Liefers GJ; Portielje JEA
    Colorectal Dis; 2017 Oct; 19(10):O358-O364. PubMed ID: 28873267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of race/ethnicity and socioeconomic status on adjuvant chemotherapy use among elderly patients with stage III colon cancer.
    Hsieh MC; Chiu YW; Velasco C; Wu XC; O'Flarity MB; Chen VW
    J Registry Manag; 2013; 40(4):180-7. PubMed ID: 24625772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use and Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer: A Population-Based Study.
    Booth CM; Nanji S; Wei X; Peng Y; Biagi JJ; Hanna TP; Krzyzanowska MK; Mackillop WJ
    J Natl Compr Canc Netw; 2016 Jan; 14(1):47-56. PubMed ID: 26733554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reasons physicians do not recommend and patients refuse adjuvant chemotherapy for stage III colon cancer: a population based chart review.
    El Shayeb M; Scarfe A; Yasui Y; Winget M
    BMC Res Notes; 2012 Jun; 5():269. PubMed ID: 22676354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients.
    Mahoney T; Kuo YH; Topilow A; Davis JM
    Arch Surg; 2000 Feb; 135(2):182-5. PubMed ID: 10668878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and complications in elderly stage III colon cancer patients in the Netherlands.
    Hoeben KW; van Steenbergen LN; van de Wouw AJ; Rutten HJ; van Spronsen DJ; Janssen-Heijnen ML
    Ann Oncol; 2013 Apr; 24(4):974-9. PubMed ID: 23136227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
    Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
    BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study.
    Kawamura H; Morishima T; Sato A; Honda M; Miyashiro I
    BMC Cancer; 2020 Jan; 20(1):19. PubMed ID: 31906959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice.
    Ananda S; Field KM; Kosmider S; Compston D; Desai J; Lim LC; Barnett FS; Jones IT; Skinner I; Gibbs P
    J Clin Oncol; 2008 Sep; 26(27):4516-7; author reply 4517-8. PubMed ID: 18802167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.